转移导向治疗在生殖尿路癌症中的作用
Katie N Lee1,2, Mai Anh Huynh3
1Harvard Radiation Oncology Program, Boston, MA, USA.
Current treatment options in oncology
|April 4, 2024
概括
以转移为导向的疗法 (MDT) 对小细胞转移性尿路癌症具有前景,可能改善结果并提供无治疗间隔. 影像和技术的进步提高了MDT的安全性和有效性.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 生殖尿道癌症 生殖尿道癌症
背景情况:
- 寡聚转移性疾病被定义为具有控制的原发性瘤的1-5个转移性部位.
- 改进的成像技术正在增加患有小细胞转移性尿路癌症的患者的鉴定.
- 转移导向疗法 (MDT) 正在成为管理这种独特临床状态的关键组成部分.
研究的目的:
- 审查MDT在小卵巢癌的发展情况.
- 讨论支持MDT改善结果的证据.
- 突出技术的进步和整合系统疗法和遗传信息.
主要方法:
- 审查当前文献和结果数据的MDT对小细胞瘤性尿路癌症.
- 讨论废除性辐射疗法的技术进步.
- 探索系统疗法和基因分析与多元化药物治疗相关的作用.
主要成果:
- 有证据表明,MDT在小细胞瘤性泌尿器癌症中的改善结果正在积累.
- 在某些患者中,MDT可以提供诸如延长全身疗法休息时间或潜在治愈等好处.
- 实时治疗适应方面的进展提高了安全性,并允许剂量升级.
结论:
- MDT代表了一种有前途的方法,为选择的患者与小细胞转移性性尿路癌症.
- 将MDT与先进的成像,全身疗法和遗传数据相结合,对于优化治疗决策至关重要.
- 需要未来的前性研究来完善患者选择,并探索协同效应的治疗组合.
更多相关视频
11:27Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
16.7K
07:50Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
Published on: May 25, 2018
8.3K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K